Matching slides 10,471
Current window 4,021-4,050
Pages 350
Rows per page 30
Slide type: Tractionclear collectionreset all

Slide type

4,021-4,050 of 10,471

filter-aware
07
The slide uses a timeline format to demonstrate regulatory milestones and credibility.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide highlights the scale of the 23andMe database and its application across three business pillars.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
16
Includes two mobile UI mockups showing personalized user results.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
20
The slide uses a gradient color scheme for the bars. The data is sourced from a 2019 survey of 1,046 customers.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
29
The slide uses a combination of a grid of metrics for general health conditions and a timeline for the COVID-19 study.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
31
The slide uses Manhattan plots to show genetic association density over time and a line chart to show the cumulative growth of independent hits.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
32
The slide uses a grid of small-multiple charts to show genetic association data across 12 medical categories. A specific example for NAFLD is highlighted at the bottom.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
40
The chart shows tumor growth inhibition over time, highlighting the triple combination (Anti-CD96 + Anti-TIGIT + Anti-PD1) as the most effective.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
59
The slide uses a 2-column layout to contrast established metrics with future/status indicators.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
06
Investor overview slide highlighting unit economics and customer loyalty.Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
19
The chart uses a background image of Crocs shoes in a Japanese street setting. The 2021E growth figure is circled.Crocs | Investor Presentation Deck | 32 slides · Crocs
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
20
Crocs | Investor Presentation Deck | 32 slidesCrocs | Investor Presentation Deck | 32 slides · Crocs
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
21
The slide uses a high-contrast, minimalist design to emphasize a single key financial metric.Crocs | Investor Presentation Deck | 32 slides · Crocs
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
22
The slide uses a graffiti-style background with two prominent metric cards.Crocs | Investor Presentation Deck | 32 slides · Crocs
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
23
The slide uses a table to demonstrate the growth trajectory and profitability of the acquired brand.Crocs | Investor Presentation Deck | 32 slides · Crocs
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
25
The slide uses a clear tabular format to contrast current year estimates with long-term goals.Crocs | Investor Presentation Deck | 32 slides · Crocs
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
27
The slide highlights deleveraging strategy following the HeyDude acquisition.Crocs | Investor Presentation Deck | 32 slides · Crocs
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
09
The slide uses two side-by-side bar charts to demonstrate historical and recent performance metrics.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
10
The slide uses a three-column layout to categorize client metrics and future growth opportunities.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
17
Includes footnotes for data verification.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
19
The slide uses a growth curve diagram to map strategic levers to performance outcomes.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
25
Includes TPG logo and page number 25.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations Beat · Business Model1 hit
27
The slide uses a series of grouped bar charts to compare capital raised across four distinct platforms (Capital, Growth, Impact, Real Estate).TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
28
The table is categorized by investment strategy (Capital, Growth, Impact, Real Estate).TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
30
The slide uses a bar chart to demonstrate operating leverage through margin expansion.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
18
The data demonstrates target engagement via IP-10 induction, a biomarker for TREM2 activation.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
19
The slide uses box plots to compare control vs mVGL101 groups across six different gene expression categories.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
20
NHP = non-human primates. Data shows dose-dependent serum concentration and CSF target engagement.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
39
The data highlights the specificity of the drug candidate for brain tissue over peripheral circulation.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
40
The slide uses box plots to compare control vs VG-3440 across six different biological metrics.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit